These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32558697)

  • 1. COVID-19 and the liver: overview.
    Amin M
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):309-311. PubMed ID: 32558697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review.
    Mohammed A; Paranji N; Chen PH; Niu B
    J Clin Gastroenterol; 2021 Mar; 55(3):187-194. PubMed ID: 33394628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic consequences of COVID-19 infection. Lapping or biting?
    Portincasa P; Krawczyk M; Machill A; Lammert F; Di Ciaula A
    Eur J Intern Med; 2020 Jul; 77():18-24. PubMed ID: 32507608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of COVID-19 patients with chronic liver diseases and liver transplants.
    Hu X; Sun L; Guo Z; Wu C; Yu X; Li J
    Ann Hepatol; 2022; 27(1):100653. PubMed ID: 34929350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.
    Feng G; Zheng KI; Yan QQ; Rios RS; Targher G; Byrne CD; Poucke SV; Liu WY; Zheng MH
    J Clin Transl Hepatol; 2020 Mar; 8(1):18-24. PubMed ID: 32274342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
    Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.
    Xu Y; Yang X; Bian H; Xia M
    Lipids Health Dis; 2021 Oct; 20(1):126. PubMed ID: 34602072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications.
    Rodriguez-Espada A; Salgado-de la Mora M; Rodriguez-Paniagua BM; Limon-de la Rosa N; Martinez-Gutierrez MI; Pastrana-Brandes S; Navarro-Alvarez N
    World J Gastroenterol; 2024 Jun; 30(22):2866-2880. PubMed ID: 38947288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic complications of COVID-19 and its treatment.
    Tian D; Ye Q
    J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms.
    Du M; Yang S; Liu M; Liu J
    Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101793. PubMed ID: 34428501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covid-19 and the cardiovascular system: a comprehensive review.
    Azevedo RB; Botelho BG; Hollanda JVG; Ferreira LVL; Junqueira de Andrade LZ; Oei SSML; Mello TS; Muxfeldt ES
    J Hum Hypertens; 2021 Jan; 35(1):4-11. PubMed ID: 32719447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host determinants and responses underlying SARS-CoV-2 liver tropism.
    Heinen N; Klöhn M; Westhoven S; Brown RJ; Pfaender S
    Curr Opin Microbiol; 2024 Jun; 79():102455. PubMed ID: 38522265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.
    Nägele MP; Haubner B; Tanner FC; Ruschitzka F; Flammer AJ
    Atherosclerosis; 2020 Dec; 314():58-62. PubMed ID: 33161318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
    Fiel MI; El Jamal SM; Paniz-Mondolfi A; Gordon RE; Reidy J; Bandovic J; Advani R; Kilaru S; Pourmand K; Ward S; Thung SN; Schiano T
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):763-770. PubMed ID: 32992052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and the liver: What do we know after six months of the pandemic?
    Fierro NA
    Ann Hepatol; 2020; 19(6):590-591. PubMed ID: 32956871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging in COVID-19-related myocardial injury.
    Cau R; Bassareo PP; Mannelli L; Suri JS; Saba L
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1349-1360. PubMed ID: 33211242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.
    Hamid S; Alvares da Silva MR; Burak KW; Chen T; Drenth JPH; Esmat G; Gaspar R; LaBrecque D; Lee A; Macedo G; McMahon B; Ning Q; Reau N; Sonderup M; van Leeuwen DJ; Armstrong D; Yurdaydin C
    J Clin Gastroenterol; 2021 Jan; 55(1):1-11. PubMed ID: 33230011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.